Presenilins and Alzheimer's disease:: the role of Aβ42

被引:0
|
作者
Eckman, CB [1 ]
机构
[1] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA
来源
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 1998年 / 53期
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The presenilin proteins, localized predominantly to the endoplasmic reticulum, are multi-transmembrane spanning proteins that are processed to form an approximately 27kD N-terminal fragment and a corresponding 19kD C-terminal fragment. Mutations in the presenilin 1 and presenilin 2 genes have been identified that cause early onset familial Alzheimer's disease Analysis of plasma and fibroblasts from patients revealed that these mutations increase the concentration of A beta 42 Cells and transgenic animals containing these mutations both give rise to increases in the extracellular concentration of this peptide providing further evidence for the role of A beta, particularly A beta 42, in Alzheimer's disease. These data provide strong evidence that alterations in A beta concentration are an early and critical event in the pathology of Alzheimer's disease.
引用
收藏
页码:181 / 184
页数:4
相关论文
共 50 条
  • [21] Role of presenilins in signal transduction pathways and cell death in Alzheimer's disease
    Popescu, B. O.
    Ankarcrona, M.
    Cedazo-Minguez, A.
    Hansson, C. A.
    Popescu, L. M.
    Cowburn, R. F.
    Winblad, B.
    FEBS JOURNAL, 2007, 274 : 167 - 167
  • [22] Presenilins as therapeutic targets for the treatment of Alzheimer's disease
    Golde, TE
    Koo, ED
    Weggen, S
    Sagi, SA
    Monnier, T
    Nyborg, A
    Das, P
    Jansen, K
    Eriksen, J
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 84 - 84
  • [23] Presenilins, Alzheimer's disease, and capacitative calcium entry
    Putney, JW
    NEURON, 2000, 27 (03) : 411 - 412
  • [24] Chromosome missegregation in Alzheimer's Disease caused by the presenilins
    Boeras, DI
    Padmanabhan, J
    Sutcliffe, M
    Nilsson, L
    Potter, H
    FASEB JOURNAL, 2002, 16 (04): : A526 - A527
  • [25] Presenilins as therapeutic targets for the treatment of Alzheimer's disease
    Golde, TE
    Younkin, SG
    TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) : 264 - 269
  • [26] Presenilins and early-onset Alzheimer's disease
    van Duijn, CM
    Cruts, M
    Backhovens, H
    Theuns, J
    Van Gassen, G
    Hofman, A
    Van Broeckhoven, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A214 - A214
  • [27] Amyloid β peptides and presenilins in the pathogenesis of Alzheimer's disease
    Iwatsubo, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1999, 32 (01) : 13 - 15
  • [28] Presenilins: Discovery and characterization of the genes of Alzheimer's disease
    Rogaev, EI
    MOLECULAR BIOLOGY, 1998, 32 (01) : 58 - 69
  • [29] Presenilins, amyloid-beta and Alzheimer's disease
    Lamb, BT
    NATURE MEDICINE, 1997, 3 (01) : 28 - 29